ARQT Sale Disclosure
Welgus Howard G. · SEC Form 4 · Filed Sep 17, 2026
Sale
Calculated transaction value
$114.37K
Welgus Howard G. Director
ARQT
Transaction date
Sep 15, 2026
Public filing date
Sep 17, 2026
Filing lag
Filed 2 days later
ARQT daily price context
Close on/before transaction
$23.51
Sep 15, 2026
Close before public filing
$26.14
Sep 16, 2026
Return since public filing
-3.52%
Through Sep 18, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 4,730 shares @ $24.18
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001628280-26-062490
Filing cohort
Transactions in this filing
Showing 7 of 7
Trades
7
Issuers
1
Estimated value
$146.85K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Arcutis Biotherapeutics, Inc. ARQT | Exercise | Sep 15, 2026 | $5.36K |
| Arcutis Biotherapeutics, Inc. ARQT | Exercise | Sep 15, 2026 | $7.65K |
| Arcutis Biotherapeutics, Inc. ARQT | Exercise | Sep 15, 2026 | $19.46K |
| Arcutis Biotherapeutics, Inc. ARQT Current | Sale | Sep 15, 2026 | $114.37K |
| Arcutis Biotherapeutics, Inc. ARQT | Exercise | Sep 15, 2026 | $0 |
| Arcutis Biotherapeutics, Inc. ARQT | Exercise | Sep 15, 2026 | $0 |
| Arcutis Biotherapeutics, Inc. ARQT | Exercise | Sep 15, 2026 | $0 |